In this webinar, Pfizer scientists share their unique insights into how process, methods, and platform factors light the way for success, driving optimized yields, accelerated timelines to market, and more reliable process and manufacturing outcomes.
A CDMO with years of experience is crucial when producing life-changing gene and cell therapies, so choosing the right partner is key. Our experts are here to help you navigate the path to market, for your gene and cell therapy.
With a team comprising over 70 expert gene and cell therapy scientists, we leverage many years of working in this space to build and optimize our gene and cell therapy platform.
Download our brochure to see how we can bring your breakthrough to light
Gene and cell therapies (GCTs) are offering life-changing new treatment options for genetic disorders. Our eBook examines the critical aspects of the development and manufacturing of GCTs and how we can help bring these therapeutics from clinical stages to commercialization.
Process development and analytical development are integral parts of gene therapy manufacturing. This whitepaper explores the analytical and development approaches needed to create a path to success in the clinic and beyond.
From adapting to budget constraints to weathering ongoing supply chain challenges, our industry experts discuss the forces that are driving current changes across the pharma and biotech sectors and share their insights into what we can expect in the market in 2023.
For over 40 years, we've been listening, solving, and guiding our partners' drug projects to success. But what makes us an altogether different kind of CDMO to work with? Find out here.
Pfizer experts are ready to help meet your complex OSD needs from our site in Ascoli, Italy.
What opportunities and obstacles will there be for CDMOs in 2024? The contract development and manufacturing organization (CDMO) realm remains one of biopharma's buzziest fields following on from the COVID-19 era.
The antibody therapeutic space has rapidly evolved over the last 30 years.
Explore our infographic to discover how we navigate the intricate sterile injectable landscape to help deliver your high-quality therapeutics to patients who need them.
In this webinar, our OSD scientists and manufacturing experts across the global Pfizer network share their unique insights on the challenges facing your OSD’s journey to market.